Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates

This publication has 39 references indexed in Scilit:

• Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen
  Blood, 2006
• USE OF LENTIVIRAL VECTORS TO INDUCE LONG-TERM TOLERANCE TO GAL+ HEART GRAFTS
  Transplantation, 2004
• Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene
  Gene Therapy, 2004
• Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells
  Proceedings of the National Academy of Sciences, 2003
• Human and Simian Immunodeficiency Virus Capsid Proteins Are Major Viral Determinants of Early, Postentry Replication Blocks in Simian Cells
  Journal of Virology, 2003
• Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection
  Gene Therapy, 2001
• Tolerization of Galα1,3Gal‐reactive B cells in pre‐sensitized α1,3‐galactosyltransferase‐deficient mice by nonmyeloablative induction of mixed chimerism
  Xenotransplantation, 2001
• Adult and neonatal anti‐Gal response in knock‐out mice for α1,3galactosyltransferase
  Xenotransplantation, 1998
• Tolerization of Anti–Galα1-3Gal Natural Antibody–forming B Cells by Induction of Mixed Chimerism
  The Journal of Experimental Medicine, 1998
• Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.
  Proceedings of the National Academy of Sciences, 1993